DaVita Inc
NYSE:DVA
DaVita Inc
Cash from Financing Activities
DaVita Inc
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
DaVita Inc
NYSE:DVA
|
Cash from Financing Activities
-$1.2B
|
CAGR 3-Years
14%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-9%
|
|
Chemed Corp
NYSE:CHE
|
Cash from Financing Activities
-$31.8m
|
CAGR 3-Years
51%
|
CAGR 5-Years
30%
|
CAGR 10-Years
13%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Cash from Financing Activities
$83m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
CVS Health Corp
NYSE:CVS
|
Cash from Financing Activities
-$1.3B
|
CAGR 3-Years
55%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
0%
|
|
Cigna Corp
NYSE:CI
|
Cash from Financing Activities
-$4.3B
|
CAGR 3-Years
20%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-17%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Cash from Financing Activities
-$10.4m
|
CAGR 3-Years
77%
|
CAGR 5-Years
63%
|
CAGR 10-Years
26%
|
See Also
What is DaVita Inc's Cash from Financing Activities?
Cash from Financing Activities
-1.2B
USD
Based on the financial report for Dec 31, 2023, DaVita Inc's Cash from Financing Activities amounts to -1.2B USD.
What is DaVita Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-9%
Over the last year, the Cash from Financing Activities growth was -4%. The average annual Cash from Financing Activities growth rates for DaVita Inc have been 14% over the past three years , -13% over the past five years , and -9% over the past ten years .